Phenotyping

#Drug discovery #Pharmaceutical industry #Phenotyping #PhoreMost #Roche

PhoreMost and Roche enter drug discovery partnership

Roche and UK-based biopharmaceutical company PhoreMost have agreed to a multi-project target discovery collaboration. Under the terms of the agreement, PhoreMost will receive an upfront payment and is eligible for preclinical success-based milestones. PhoreMost will deploy its phenotypic screening platform, SITESEEKER, toward disease-relevant pathways nominated by Roche. Novel targets identified… Read More

#Business & Investment #News

A laboratory mouse
#Animal models #Animal testing #Genetic editing #Genetics #Phenotyping

NIH renews knockout mouse project for 3rd time

The University of California, Davis, has received over $12 million from the National Institutes of Health for the third and final five-year phase of the Knockout Mouse Phenotyping Project (KOMP2). ‘Knockout’ mice are bred in a laboratory with specific genes silenced or ‘knocked out’. They have been valuable tools for… Read More

#News